ELEDON PHARMACEUTICALS INC's ticker is ELDN and the CUSIP is 28617K101. A total of 29 filers reported holding ELEDON PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $61,228 | 0.0% | 44,692 | 0.0% | 0.00% | – |
| Q2 2023 | $61,228 | -41.9% | 44,692 | 0.0% | 0.00% | – |
| Q1 2023 | $105,473 | -49.1% | 44,692 | -50.0% | 0.00% | – |
| Q4 2022 | $207,370 | +68.6% | 89,384 | +100.0% | 0.00% | – |
| Q3 2022 | $123,000 | +12.8% | 44,692 | 0.0% | 0.00% | – |
| Q2 2022 | $109,000 | -38.1% | 44,692 | 0.0% | 0.00% | – |
| Q1 2022 | $176,000 | -1.1% | 44,692 | +10.5% | 0.00% | – |
| Q4 2021 | $178,000 | -28.8% | 40,435 | 0.0% | 0.00% | – |
| Q3 2021 | $250,000 | -4.2% | 40,435 | +22.8% | 0.00% | – |
| Q2 2021 | $261,000 | – | 32,935 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 245,000 | $676,000 | 0.76% |
| BVF INC/IL | 2,326,710 | $6,422,000 | 0.26% |
| Cormorant Asset Management, LP | 1,223,500 | $3,377,000 | 0.24% |
| Ikarian Capital, LLC | 221,830 | $612,000 | 0.12% |
| JMAC ENTERPRISES LLC | 54,538 | $151,000 | 0.04% |
| Woodline Partners LP | 516,675 | $1,426,000 | 0.02% |
| Eversept Partners, LP | 67,743 | $186,971 | 0.02% |
| INGALLS & SNYDER LLC | 51,149 | $141,000 | 0.01% |
| Point72 Asset Management, L.P. | 375,000 | $1,035,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 22,050 | $61,000 | 0.00% |